Twenty one days after xenograft, 2‐DG treatment significantly delayed the growth rate and reduced the tumour volume in ASPP2‐silenced HCC‐LM3 xenografts (Figure 6A). This evidence concerns the gene TP53BP2 and hepatocellular carcinoma.